MEDIMMUNE

MedImmune, the global biologics research and development arm of AstraZeneca, and Abpro, an integrated life sciences company at the forefront of...

Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond Global supply...

Today, antimicrobial resistance from antibiotic misuse and overuse poses an imminent and urgent public health threat, making it more important...

AstraZeneca and the University of Oxford today announced an agreement for the global development and distribution of the University’s potential...

The $1bn programme will include the launch of next-generation respiratory inhalers and a wide range of energy initiatives to reduce climate...